Zenas BioPharma
ZBIO
23.85
-1.19
-4.75%
Zenas BioPharma
US · ZBIO
#2856 by market cap
Listed 2024
23.85
-1.19
-4.75%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
About Zenas BioPharma
Zenas BioPharma, Inc. is a clinical-stage global biopharmaceutical company, which engages in the development and commercialization of transformative immunology-based therapies for patients. The company was founded by Lonnie O. Moulder Jr on November 12, 2019 and is headquartered in Waltham, MA.
- Founded
- 2019
- CEO
- Mr. Leon Oliver Moulder, Jr
- Employees
- 167
- Headquarters
- Waltham, Massachusetts, United States of America
- Fiscal year end
- 12-31
- Website
- zenasbio.com
Company profile
- Exchange
- US
- Symbol
- ZBIO
- Market-cap rank
- #2856
- Listing date
- 2024-09-13
- Market cap
- 1.62B
- Float cap
- 950.22M
- Shares out
- 67.82M
- Float shares
- 39.84M
Sectors & themes
Biotechnology
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Zenas BioPharma discussion 0 comments